Please visit answersincme.com/UNV860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in dermatology, immunology, and rheumatology discuss the management of psoriatic arthritis with novel targeted therapies. Upon completion of this activity, participants should be better able to: Recognize the rationale for novel TYK2 inhibitors in the treatment of psoriatic arthritis; Describe the latest clinical data informing the role of TYK2 inhibitors in the treatment of psoriatic arthritis; and Outline future management considerations for novel TYK2 inhibitors in the treatment of psoriatic arthritis.
Fler avsnitt av CME in Minutes: Education in Primary Care
Visa alla avsnitt av CME in Minutes: Education in Primary CareCME in Minutes: Education in Primary Care med Answers in CME finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
